FIELD: medicine.
SUBSTANCE: composition for nasal application, containing active and additive ingredients, wherein the active ingredients are presented by sea salt and α-glutamyl-tryptophan in the following ratio of the active ingredients (wt %): sea salt 95.00-98.00; alpha-glutamyl-tryptophan 2.00-5.00. The group of inventions also refers to a therapeutic agent, a method, using and a medical device for preventing or treating upper airway diseases.
EFFECT: group of inventions promotes slime evacuation, reduces infected nasal discharge and relieves swollen mucosa, softens and removes crusts and enhances body defences, as well as normalises the barrier function of nasal mucosa epithelium, improves nasal breathing and causes moistening and anti-inflammatory action.
18 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NASAL MEDICINE MORENAZAL | 2007 |
|
RU2369397C2 |
| COMPOSITION FOR NASAL PREPARATION | 2015 |
|
RU2605617C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF UPPER RESPIRATORY TRACT DISEASES AND MEDICINAL PRODUCT BASED THEREON | 2019 |
|
RU2748548C1 |
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
| ANTI-VIRAL IMMUNOTROPIC AGENT FOR TREATMENT OF ARVI | 2018 |
|
RU2672888C1 |
| TREATMENT OF ALLERGIC RHINITIS USING COMBINATION OF MOMETASONE AND OLOPATADINE | 2014 |
|
RU2686670C2 |
| TREATMENT OF ALLERGIC RHINITIS IN PEDIATRIC CATEGORY USING A COMBINATION OF MOMETASONE AND OLOPATADINE | 2019 |
|
RU2798030C2 |
| METHOD FOR TREATMENT AND PREVENTION OF ALLERGIC SPECTRUM STATES | 2016 |
|
RU2635968C1 |
| MEANS FOR NASAL APPLICATION | 2016 |
|
RU2629330C1 |
| METHOD OF REHABILITATION OF WORKERS WITH CHRONIC OCCUPATIONAL DISEASES OF RESPIRATORY ORGANS: RHINOPHARYNGITIS, TRACHEOBRONCHITIS CAUSED BY EXPOSURE TO HARMFUL FACTORS OF TITANIUM-MAGNESIUM PRODUCTION | 2019 |
|
RU2716962C1 |
